Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6VUM

Structure of nevanimibe-bound human tetrameric ACAT1

6VUM の概要
エントリーDOI10.2210/pdb6vum/pdb
EMDBエントリー21390
分子名称Sterol O-acyltransferase 1, OLEIC ACID, CHOLESTEROL, ... (6 entities in total)
機能のキーワードcholesterol, cholesteryl ester, acyltransferase, mboat, membrane protein
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数4
化学式量合計273486.88
構造登録者
Li, X.,Long, T. (登録日: 2020-02-16, 公開日: 2020-05-13, 最終更新日: 2024-03-06)
主引用文献Long, T.,Sun, Y.,Hassan, A.,Qi, X.,Li, X.
Structure of nevanimibe-bound tetrameric human ACAT1.
Nature, 581:339-343, 2020
Cited by
PubMed Abstract: Cholesterol is an essential component of mammalian cell membranes, constituting up to 50% of plasma membrane lipids. By contrast, it accounts for only 5% of lipids in the endoplasmic reticulum (ER). The ER enzyme sterol O-acyltransferase 1 (also named acyl-coenzyme A:cholesterol acyltransferase, ACAT1) transfers a long-chain fatty acid to cholesterol to form cholesteryl esters that coalesce into cytosolic lipid droplets. Under conditions of cholesterol overload, ACAT1 maintains the low cholesterol concentration of the ER and thereby has an essential role in cholesterol homeostasis. ACAT1 has also been implicated in Alzheimer's disease, atherosclerosis and cancers. Here we report a cryo-electron microscopy structure of human ACAT1 in complex with nevanimibe, an inhibitor that is in clinical trials for the treatment of congenital adrenal hyperplasia. The ACAT1 holoenzyme is a tetramer that consists of two homodimers. Each monomer contains nine transmembrane helices (TMs), six of which (TM4-TM9) form a cavity that accommodates nevanimibe and an endogenous acyl-coenzyme A. This cavity also contains a histidine that has previously been identified as essential for catalytic activity. Our structural data and biochemical analyses provide a physical model to explain the process of cholesterol esterification, as well as details of the interaction between nevanimibe and ACAT1, which may help to accelerate the development of ACAT1 inhibitors to treat related diseases.
PubMed: 32433613
DOI: 10.1038/s41586-020-2295-8
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.67 Å)
構造検証レポート
Validation report summary of 6vum
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon